Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial

Brian A. Bergmark,Deepak L. Bhatt,Darren K. McGuire,Avivit Cahn,Ofri Mosenzon,Ph. Gabriel Steg,KyungAh Im,Estella Kanevsky,Yared Gurmu,Itamar Raz,Eugene Braunwald,Benjamin M. Scirica,investigators

Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial

2019

Brian A. Bergmark
Deepak L. Bhatt
Darren K. McGuire
Avivit Cahn
Ofri Mosenzon
Ph. Gabriel Steg
KyungAh Im
Estella Kanevsky
Yared Gurmu
Itamar Raz
Eugene Braunwald
Benjamin M. Scirica
investigators

Background: Metformin is first line therapy for type 2 diabetes mellitus (T2DM) although its effects on the cardiovascular (CV) system are unproved. Methods: In this post hoc analysis, patients in ...

Keywords:

Type 2 Diabetes Mellitus
Heart failure
Diabetes mellitus
Metformin
Kidney dysfunction
Cardiology
Internal medicine
Post-hoc analysis
TIMI
Medicine

Correction
Cite
Save
Machine Reading By IdeaReader

References

Citations